Effectiveness of an intervention to facilitate prompt referral to memory clinics in the United Kingdom: Cluster randomised controlled trial
Gill Livingston and colleagues present results of a cluster randomized controlled trial of an intervention aimed to facilitate prompt referral to memory clinics and increase early diagnosis of dementia in the United Kingdom.
Vyšlo v časopise:
Effectiveness of an intervention to facilitate prompt referral to memory clinics in the United Kingdom: Cluster randomised controlled trial. PLoS Med 14(3): e32767. doi:10.1371/journal.pmed.1002252
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002252
Souhrn
Gill Livingston and colleagues present results of a cluster randomized controlled trial of an intervention aimed to facilitate prompt referral to memory clinics and increase early diagnosis of dementia in the United Kingdom.
Zdroje
1. Prince M, Wimo A, Guerchet M, Ali G, Wu YT, Prina M. World Alzheimer Report 2015—The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends. 2015. London, Alzheimer's Disease International (ADI).
2. Kosteniuk JG, Morgan DG, O'Connell ME, et al. Incidence and prevalence of dementia in linked administrative health data in Saskatchewan, Canada: a retrospective cohort study. BMC Geriatr 2015; 15:73. doi: 10.1186/s12877-015-0075-3 26135912
3. Mukadam N, Cooper C, Kherani N, Livingston G. A systematic review of interventions to detect dementia or cognitive impairment. Int J Geriatr Psychiatry 2015; 30(1):32–45. doi: 10.1002/gps.4184 25132209
4. Robinson L, Tang E, Taylor JP. Dementia: timely diagnosis and early intervention. BMJ 2015; 350:h3029. doi: 10.1136/bmj.h3029 26079686
5. Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 2012; 366(10):893–903. doi: 10.1056/NEJMoa1106668 22397651
6. Livingston G, Kelly L, Lewis-Holmes E, Biao G, Morris S, Patel N, et al. Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials. Br J Psychiatry 2014; 205(6):436–442. doi: 10.1192/bjp.bp.113.141119 25452601
7. Livingston G, Barber J, Rapaport P, Knapp M, Griffin M, King D, et al. Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial. BMJ 2013; 347:f6276. doi: 10.1136/bmj.f6276 24162942
8. Banerjee S, Wittenberg R. Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. Int J Geriatr Psychiatry 2009; 24(7):748–754. doi: 10.1002/gps.2191 19206079
9. Pinner G, Bouman WP. Attitudes of patients with mild dementia and their carers towards disclosure of the diagnosis. Int Psychogeriatr 2003; 15(3):279–288. 14756163
10. Olafsdottir M, Foldevi M, Marcusson J. Dementia in primary care: why the low detection rate? Scand J Prim Health Care 2001; 19(3):194–198. 11697565
11. Livingston G, Leavey G, Manela M, Livingston D, Rait G, Sampson E, et al. Making decisions for people with dementia who lack capacity: qualitative study of family carers in UK. BMJ 2010; 341.
12. Department of Health. Living well with dementia: A National Dementia Strategy. 2009.
13. Bunn F, Goodman C, Sworn K, Rait G, Brayne C, Robinson L, et al. Psychosocial factors that shape patient and carer experiences of dementia diagnosis and treatment: a systematic review of qualitative studies. PLoS Med 2012; 9(10):e1001331. doi: 10.1371/journal.pmed.1001331 23118618
14. Gove D, Downs M, Vernooij-Dassen M, Small N. Stigma and GPs' perceptions of dementia. Aging Ment Health 2015; 1–10.
15. Teel C, Carson P. Family experiences in the journey through dementia diagnosis and care. Journal of Family Nursing 9[1], 38–58. 2011.
16. Werner P, Goldstein D, Karpas DS, Chan L, Lai C. Help-seeking for dementia: a systematic review of the literature. Alzheimer Dis Assoc Disord 2014; 28(4):299–310. doi: 10.1097/WAD.0000000000000065 25321607
17. Robb K, Power E, Kralj-Hans I, et al. Flexible sigmoidoscopy screening for colorectal cancer: uptake in a population-based pilot programme. J Med Screen 2010; 17(2):75–78. doi: 10.1258/jms.2010.010055 20660435
18. Morbidity Information and Export Syntax (MIQUEST). 2016. NHS Digital. URL: http://systems.digital.nhs.uk/data/miquest
19. Medical Research Council. Cluster randomised trials: Methodological and ethical considerations. 1–16. 2002. Medical Research Council. MRC clinical trials series.
20. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj.a1655 18824488
21. Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State—Practical Method for Grading Cognitive State of Patients for Clinician. J Psychiatr Res 1975; 12(3):189–198 1202204
22. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21(11):1078–1085. doi: 10.1002/gps.1610 16977673
23. Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord 2013; 36(3–4):242–250. doi: 10.1159/000351671 23949210
24. Office National Statistics. Mid-year population estimates. 2010. Office for National Statistics; General Register Office for Scotland; Northern Ireland Statistics and Research Agency.
25. Burback D, Molnar FJ, St JP, Man-Son-Hing M. Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration. Dement Geriatr Cogn Disord 1999; 10(6):534–540.
26. Machin D, Campbell M, Tan S, Tan S. Sample Size Tables for Clinical Studies. Third ed. Wiley-Blackwell; 2009.
27. Newman JC, Feldman R. Copyright and open access at the bedside. N Engl J Med 2011; 365(26):2447–2449. doi: 10.1056/NEJMp1110652 22204721
28. Law E, Connelly PJ, Randall E, McNeill C, Fox HC, Parra MA, et al. Does the Addenbrooke's Cognitive Examination-revised add to the Mini-Mental State Examination in established Alzheimer disease? Results from a national dementia research register. Int J Geriatr Psychiatry 2013; 28(4):351–355. doi: 10.1002/gps.3828 22556006
29. Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. Journal of Statistical Software 2011; 45(3):1–67.
30. Rubin D. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987.
31. Mitchie S, van Stralen M, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Science 2011; 6(42).
32. Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I. Survival of people with clinical diagnosis of dementia in primary care: cohort study. BMJ 2010; 341:c3584 doi: 10.1136/bmj.c3584 20688840
33. Mukadam N, Livingston G, Rantell K, Rickman S. Diagnostic rates and treatment of dementia before and after launch of a national dementia policy: an observational study using English national databases. Bmj Open 2014; 4(1).
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2017 Číslo 3
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Effectiveness of an intervention to facilitate prompt referral to memory clinics in the United Kingdom: Cluster randomised controlled trial
- , , and mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases
- Rehabilitation for people living with dementia: A practical framework of positive support
- Dementia in low-income and middle-income countries: Different realities mandate tailored solutions